The last time a single injection changed the trajectory of medicine, it was insulin, and that was over a century ago. On June 9, 2026, a human being received a shot that scientists are calling ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Today, a brief rundown of news involving AstraZeneca and SonoThera, as well as updates from Bausch + Lomb, Cartesian Therapeutics and Eli Lilly and that you may have missed. Enhertu, Datroway and ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

Beyond headlines and promises of eternal youth, advances in transplants, epigenetic clocks, and cellular reprogramming are redefining aging to help people live longer — and, above all, healthier. Some ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. During ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...